Friday, 9 June 2017

Cancer Drug Proves to Be Effective Against Multiple Tumors

Cancer Drug Proves to Be Effective Against Multiple Tumors

The drug, pembrolizumab, sold as Keytruda, is the first approved for patients with tumors with a particular genetic signature, wherever they appear in the body. Just 4 percent of cancer patients have the type of genetic aberration susceptible to pembrolizumab. But that adds up to a lot of patients: as many as 60,000 each year in the United States alone, the study’s investigators estimated.

Continue reading...

No comments:

Post a Comment